Presentation is loading. Please wait.

Presentation is loading. Please wait.

CASO CLINICO Il paziente naϊve ad alta viremia Rapido sviluppo di resistenza ad EFV dopo solo 4 mesi di terapia.

Similar presentations


Presentation on theme: "CASO CLINICO Il paziente naϊve ad alta viremia Rapido sviluppo di resistenza ad EFV dopo solo 4 mesi di terapia."— Presentation transcript:

1 CASO CLINICO Il paziente naϊve ad alta viremia Rapido sviluppo di resistenza ad EFV dopo solo 4 mesi di terapia

2 On December 2011 Viremia: 624734 copies/ml CD4: 19 cells/µl Risk Factor Heterosex Clinical Case : ID 13268 Patient infected with HIV-1 CRF01_AE Age 43 Sex F CDC stage C3 I Seropositivity December 2011 in out DECEMBER 2011 – APRIL 2012 TDF+TFC+EFV GRT April 2012 PR: K20R, M36I, L63P, L89I, I93L RT: K103N, Y188H/Y in out Other pol mutations PR: T12I/T, I13V, E35D, N37D, R41K, K43R, H69K RT: E6D, V35T, T39K, K43E, F61F/L, D121H, K122E, I142V, S162A, K173I, Q174K, D177E, Q207A, R211S, V245E, A272P, V276I, T286A, E291D, V292I, I293V, E312T, I326V, Q334R, G335D GRT December 2011 PR: K20R, M36I, L63P, L89I, I93L RT: NONE Other pol mutations PR: I13V, Q18H/Q, E35D, N37D, R41K, K43R, H69K RT: E6D, V35T, T39K, K43E, D121D/H, I142V, S162A, K173I, Q174K, D177E, G196EG, I202IV, Q207A, R211S, V245E, A272P, V276IV, T286A, E291D, V292I, I293V, E312T, I326V Rapid appearance resistance to TDF and EFV after only four months of therapy

3 PR ATV/r DRV/r FPV/r IDV/r LPV/r NFV SQV/r TPV/r Total: 00000000 RT 3TC ABC AZT D4T DDI FTC TDF EFV ETR NVP RPV Total: 00000000000 Mutation scoring* for the protease * Stanford Algorithm (http:hivdb.stanford.edu) Mutation scoring* for the reverse transcriptase GRT December 2011 RT 3TC ABCAZTD4TDDIFTCTDFEFVETRNVPRPV K103N-------600 0 Y188H-------300600 Total: 0005200299001200 GRT April 2012 PR ATV/r DRV/r FPV/r IDV/r LPV/r NFV SQV/r TPV/r Total: 00000000 Susceptible virus Virus low level of resistance Virus intermediate resistance Virus high level of resistance Risk Factor Heterosex Clinical Case : ID 13268 Patient with HIV-1 CRF01_AE subtype Age 43 Sex F CDC stage C3 I Seropositivity December 2011


Download ppt "CASO CLINICO Il paziente naϊve ad alta viremia Rapido sviluppo di resistenza ad EFV dopo solo 4 mesi di terapia."

Similar presentations


Ads by Google